2026
Min J, Cho E, Shin S, Choi YJ. Adverse event reporting patterns of tobacco cessation medications in Korea: A Disproportionality analysis. Healthcare 2026; 14,3479
Lee SH, Lee S, Lee S, Choi YJ. Machine-learning-driven pharamcovigilance of antidiabetic drugs: comparative reproting patterns and classification of serious adverse events. Eur J Clin Pharmacol 2026;82:266
Lee SH, Rho Y, Lee S, Shin S, Choi YJ. Comparative neuroprotective effects of antidiabetic medications on Parkinson's disease risk: A Bayesian network meta-analysis. J Glob Health 2026;16:04187
Moon S, Lee E, Kim D, Choi KH, Choi YJ*, Shin S*. Psychiatric safety signals of GLP-1receptor agonists: A FAERS-based pharmacovigilance study with explainable machine learning. Pharamceuticals 19, 963
Moon S, Choi HY, Choi YJ*, Shin S*. Clinical efficacy and safety profile of bimekizumab in psoriasis: A systemtatic review and meta-analysis of randomized controlled trials. Endocr Metab Immune Disord Drug Targets 2026;e18715303446173
Kim Y, Sohn YJ, Yoo JY, Kim M, Kim S, Choi YJ. Predicting serious adverse events, medication abuse, misuse, and risk of dependence for medications with high dependence potential: Role of patient-reported factors and machine learning approach. Healthcare 2026; 14:1265
Lee S, Park S, Shin MG, Jo HG, Jeong K, Yoon JE, Ye KN, Choi YJ, Choe M, Yang S, Kang P, Kim JT, Kang SW, Chung EK. Clinical impact of a multidisciplinary remote-based hybrid antibiotic stewardship program in critically ill patients during COVID-19 pandemic in Korea: a prospective pilot implementation study. Antimicrob Resist Infect Control 2026;15:62
Kim Y, Choo E, Shin S, Choi YJ. Comparative risk of psychiatric comorbidities associated with codeine and tramadol in patients with hip osteoarthritis: a nationwide population-based cohort study. J Glob Health 2026;16:04121
Moon S, Kang DW, Choi YJ*, Shin S. Signal detection and machine learning-based prediction of cytokine release syndrome in B-cell maturation antigen-targeting immunotherapies using FAERS data. Pharmaceuticals 2026;19,669 (co-correspondence)
Lee J, Kim Y, Choo E, Shin S, Choi YJ. Psychiartic, cardiovascular and skeletal risks of codeine versus oxycodone in hip osteoarthirits: A population-based cohort study. Drug Des Devel Ter 2026;20:572083
2025
Moon S, Choo E, Choi YJ, Shin S. Comparatice cardiovacular safety of duloxetine and gabapentin in patinets with hip osteoarthirtis. J Pain Res 2025;18:6437-6448 (co-corespondence)
Min J, Lee JE, Cho E, Im J, Choi YJ. Pharmacovigilance signal detection of drug-induced hospitalizations and mortality: A 5-year nationwide study. Healthcare 2025:13, 2921
Lee SH, Choi Y, Choi CY, Choi YJ*, Shin S*. Mortality risk of colistin vs. non-colistin use in cancer patients with multidrug-resistant gram-negative bacterial infections: Startified by resistance profile and concomitant medications. Medicina 2025;61:1361 (co-corespondence)
Lee SH, Sung DH, Cho E, Min J, Shin S, Choi YJ. Investigation into safety profiles of antiepileptic drugs and identifcation of predictors for serious adverse events: Insights from National pharmacovigilance data. Pharmaceuticals 2025; 18:1013
Han J*, Kim M*, Kim Y, Lee SH, Shin S, Choi YJ. Identifying predictors of serious adverse events in antidepressant treatment from a decade-long nationwide pharmacovigilance study: Impact of demetnai and Parkinson's disease treatment. Medicina 2025;61:1103
Mo SH, Lee SH, Choi CY, Sunwoo Y, Shin S, Choi YJ*. A comprehensive 10-year nationwide pharmacovigilance surveillance on antibacterial agents in Korea: Data mining for signal detection of trends and seriousness of adverse events. Microorganisms 2025;13:136
2024
Moon S, Ko M, Choi YJ*, Shin S*. Real-world data mining for signal detection of antipsychotics-associated adverse events using the Korea Adverse Event Reporting System (KAERS) database. Medicina 2024;60:1714 (co-corresponding)
Song E, Shim WS, Choi D, Song Y, Jo HG, Lee S, Jung SH, Choi YJ*, Lee KT*. Development of a simple and validated LC-MS/MS Method for quantitative determination of ketotifen in Beagle dog plasma and its application to bioequivalence study of ketotifen syrup dosage form. Molecules 2024;29(18):4505 (co-corresponding)
Sunwoo Y, Eom SH, Yun JS, Kim Y, Lee J, Lee SH, Shin S, Choi YJ*. Real-world data-derived pharmacovigilance on drug-induced cognitive impairment utilizing a nationwide spontaneous adverse reporting system. Medicina 2024; 60(7):1028
Sunwoo Y, Park J, Choi CY, Shin S, Choi YJ*. Risk of dementia and Alzheimer's disease associated with antidiabetics: A Bayesian network meta-analysis. Am J Prev Med 2024; 67(3):434-443
Kim B, Park B, You S, Jung SH, Lee S, Lim K, Choi YJ, Kim JH, Lee S. Cell membrane camouflaged nanoparticle strategy and its application in brain disease: a review. J Pharm Invest 2024; e-pub (May 22 2024)
Shin S, Moon S, Wang J, Choi YJ. Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studies. J Glob Health 2024;14:04074
Son J, Kim S, Porsuk T, Shin S*, Choi YJ*. Clinical outcomes of colistin methanesulfonate sodium in correlation with pharmacokinetic parameters in critically ill patients with multi-drug resistant bacteria-mediated infection: A systematic review and meta-analysis. J Infect Public Health 2024;17(5):843-853
Kim Y, Choi CY, Sunwoo Y, Go C, Kim S, Eom SH, Shin S*, Choi YJ*. A real-world data derived pharmacovigilance investigation assessment on drug-induced nephropathy:Implication on gaps in patient care. Healthcare 2024;12(1):95
2023
Go C, Kim S, Kim Y, Sunwoo Y, Eom SH, Yun J, Shin S*, Choi YJ*. A real-world data driven pharmacovigilance investigation on drug-induced arrhythmia using KAERS DB, a Korean nationwide adverse drug reporting system. Pharmaceuticals 2023;16(11):1612
Park S, Jeong J, Woo Y, Choi YJ*, Shin S*. Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients. Sci Rep 2023;13:18462 (co-correspondence)
Choi YJ, Choi CY, Kim CU, Shin S. A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication. J of Glob Health 2023;13:04095
Bak K, Moon S, Ko M, Choi YJ*, Shin S*. Impact of metformin on statin-associated myopathy risks in dyslipidemia patients. Pharmacol Res Perspect 2023;11:e01114 (co-correspondence)
Choi S, Shim WS, Yoon J, Choi D, Song E, Choi YJ, Paik SH, Lee KT. Method development and validation for the simultaneous quantitation of pentoxifylline, its pharmacologically active metabolites, and donepezil using LC-MS/MS in rat plasma: its application to a pharmacokinetic study. Separations 2023;10:276
Cho M, Choi CY, Choi YJ*, Rhie SJ*. Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis. Sci Rep 2023;13:5727 (co-correspondence)
Yoon J, Choi D, Shim WS, Choi S, Choi YJ, Paik SH, Lee KT. Development of a rapid LC-MS/MS Method for simulatneous quantification of donepezil and tadalafil in rat plasma: Its application in a pharmacokinetic interaction study after oral administration in rats. Molecules 2023;28:2352
2022
Yoon K, Kim JT, Kwack WG, Kim D, Lee K, Yang S, Lee S, Choi YJ*, Chung EK. Potentially inappropriate medication use in patients with dementia. Int J Environ Res Public Health 2022; 19(18):11426 (co-correspondence)
Choi YJ*, Choi CY, Rhie SJ, Shin S. Safety assessment on serious adverse events of targeted therapeutic agents prescribed for RAS wild-type metastatic colorectal cancer: systematic review and network meta-analysis. Int J Environ Res Public Health 2022; 19(15):9169
Son J, Kwack WG, Chung EK, Shin S, Choi YJ*. Effects of early initiation of high-dose dexamethasone therapy on pro-inflammatory cytokines and mortality in LPS-challenged mice. Healthcare 2022; 10(7):1247
Han YN, Choi YJ*, Rhie SJ. Tolerability on serious adverse events of first-line bevacizumab and cetuximab for RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. Healthcare 2022;10(2):217 (co-first)
Jo HG, Jeong K, Ryu JY, Park S, Choi YS, Kwack WG, Choi YJ*, Chung EK. Fatal events associated with adverse drug reactions in the Korean national pharmacovigilance database. J Pers Med 2022;12:5 (co-correspondence)
2021
Choi YJ, Bak K, Yeo Y, Choi Y, Shin S. Incident type 2 diabetes risk of selective estrogen receptor modulators in female patients with breast cancer. Pharmaceuticals 2021;14:925
Choi YJ, Yang SW, Kwack WG, Lee JK, Lee TH, Jang JY, Chung EK. Comparative safety profiles of sedatives commonly used in clinical practice: A 10-year nationwide pharmacovigilance study in Korea. Pharmaceuticals 2021; 14:783
Son J, Shin S, Choi YJ. New evidence of potential benefits of dexamethasone and added on therapy of fludrocortisone on clinical outcomes of corticosteroid in sepsis patients: a systematic review and meta-analysis. J Pers Med 2021; 11:544
Choi YJ, Choi YW, Chae J, Yun H, Shin S. Clinical benefits of oral anticoagulant use in cancer patients at increased risk for venous thromboembolism per Kohrana index. Risk Manag Healthc Policy 2021;14:1855-1867
Choi YJ, Shin S. Aspirin prophylaxis during pregnancy: A systematic review and meta-analysis. Am J Prev Med 2021;61:e31-45
Park S, Choi YJ, Kang JE, Kim MG, Geum MJ, Kim SD, Rhie SJ. P2Y12 antiplatelet choice for patients with chronic kidney disease and acute coronary syndrome : a systematic review and meta-analysis. J Pers Med 2021;11(3):222 (co-first)
Choi YJ, Noh YJ, Shin S. Ferric citrate in the management of hyperphosphatemia and iron deficiency anaemia: A meta-analysis in patients with chronic kidney disease. Brit J Clin Pharm 2021;87(2):414-426
2020
Choi YJ, Kim MH, Chung EK, Lee JK, Yoon J, Yug JS, Jang DK. Prevalence and seriousness of analgesic-induced adverse events in Korea: A 10-year nationwide surveillance. J Patient Saf 2020;16:e215-e224
Choi YJ, Jeon S, Shin S. Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without Type 2 diabetes: A meta-analysis of randomized controlled trials. Nutrients 2020. 12(7):2005
Choi YJ, Shin S. Impact of multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients. Brit J Clin Pharm 2020.86(5):903-912
2019
Choi YJ, Kim DJ, Shin S. Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus. Cancer Manag Res 2019. 11:7427-7438
Choi YJ, Kim HA. Effect of pharmacy-led medication reconciliation in emergency departments: a systematic review and meta-analysis. J Clin Pharm Ther 2019. 44(6):932-945
Na JD, Choi YJ, Jun DS, Kim YC. Alleviation of paraquat-induced oxidative lung injury by betaine via regulation of sulfur-containing amino acid metabolism despite the lack of betaine-homocysteine methyltransferase (BHMT) in the lung. Food Funct 2019.10:1225-1234
2018
Choi YJ, Na JD, Jun DS, Kim YC. Protective effect of betaine against galactosamine-induced acute liver injury in rats. J Funct Foods 2018.44:65-73
2016
Ahn CW, Jun DS, Na JD, Choi YJ, Kim YC. Alleviation of hepatic fat accumulation by betaine involves reduction of homocysteine via up-regulation of betaine-homocysteine methyltransferase (BHMT). Biochem Biophys Res Commun 2016.477:440-447
2015
Ahn CW, Choi YJ, Hong SH, Jun D, Na J, Choi YJ, Kim YC. Involvement of multiple pathways in the protection of liver against high-fat diet-induced steatosis by betaine. J Funct Food 2015;17:66-72